Study Stopped
investigator changed institutions-in process of transferring study to VCU
BRAIN-HEART Ultrasound Study Normative Values for Transcranial Doppler Based Cerebral Blood Flow Assessment
MCS
Cerebrovascular Investigation Relative to Systemic Circulatory Parameters Using Longitudinal Assessments on Transcranial Doppler to Evaluate Mechanical Circulatory Support [CIRCULATE-MCS]
1 other identifier
observational
6
1 country
1
Brief Summary
There is a dire need to establish normative values for transcranial Doppler(TCD) derived cerebral blood flow parameters for each type of Mechanical circulatory support (MCS) device and explore the relationship between the MCS device's systemic flow dynamics and TCD based cerebral flow(CBF) parameters TCD derived cerebral blood flow parameters can then be investigated as targets used to titrate systemic flow dynamics from MCS. Having target flow rates titrated to patient specific condition using TCD may help avoid both hypoperfusion as well as the possibility of hyperemia reperfusion injury contributing to neurological morbidity. We propose a multicenter study to gather normative data on TCD derived CBF and MCS systemic dynamics for a wide range of patient demographics. Such data collection is only possible with multi-center collaboration given the small volume of patients with MCS patients in each center.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started May 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 13, 2023
CompletedFirst Posted
Study publicly available on registry
June 29, 2023
CompletedStudy Start
First participant enrolled
May 22, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 22, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 22, 2025
CompletedApril 2, 2026
March 1, 2026
1.6 years
April 13, 2023
March 27, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Normative range of transcranial Doppler intracranial flow velocity - Baseline
Normal mean velocity of the intracranial blood vessels (Middle cerebral artery (MCA), Internal carotid artery (ICA) Posterior Cerebral Arteries (PCA), Anterior Cerebral Artery (ACA), Basilar and Vertebral A )is usually \< 80 cm/s in patients with normal cardiac output. We will explore the range of normal values of intracranial vessel velocity in patients with different degree/ type of MCS devices adjusted to the contribution of LV to blood flow 0-10 L/min
Baseline
Normative range of transcranial Doppler intracranial flow velocity- daily up to 2 years
Assess serial changes in intracranial vessel velocity ( MCA, ICA PCA, ACA, Basilar and Vertebral A ) that occur with changes in systemic dynamics related to change in MCS settings
daily up to 2 years
Normative range of transcranial Doppler-derived pulsatility index
Normal pulsatility index for intracranial vessels index ( MCA, ICA PCA, ACA, Basilar and Vertebral A ) is 0.6-1.2 in patients with normal cardiac output. We will describe the correlation between transcranial Doppler-derived Pulsatility index and degree/ type of mechanical circulatory support and the contribution of LV to blood flow 0-10 L/min
Baseline
Normative range of transcranial Doppler-derived pulsatility index- daily up to 2 years
Assess serial changes in transcranial Doppler-derived pulsatility index ( MCA, ICA PCA, ACA, Basilar and Vertebral A ) that occur with changes in systemic dynamics related to change in MCS settings
daily up to 2 years
Secondary Outcomes (2)
Number of neurological complications observed in patients enrolled in the study
Baseline and daily up to 2 years
Association of abnormalities seen in cerebral blood flow assessed using transcranial Doppler-derived
Up to 2 years
Study Arms (1)
Transcranial Doppler
Serial daily TCD during the ICU stay involving bilateral Middle cerebral artery (MCA) insonation
Eligibility Criteria
Patients admitted to the intensive care unit or inpatient wards for cardiogenic shock requiring mechanical circulatory support
You may qualify if:
- \>18 years old on the day of enrollment
- Mechanical circulatory support
- a. Left Ventricular Assist Device \[HeartMate-III\] in antegrade flow i. Critically ill ii. With and without pulsatility b. Impella antegrade flow c. VA-ECMO (VA-ECMO) is a temporary mechanical circulatory support system that enables complete and immediate cardiopulmonary support in the setting of cardiogenic shock and cardiac arrest) retrograde flow usual with femoral cannulation or antegrade flow if centrally cannulated
- Patient must be in the intensive care unit or in patient for the intervention to be performed
You may not qualify if:
- Known cerebrovascular disease or know angiographic abnormalities based on preexisting computed tomography angiography, digital subtraction angiography or transcranial Doppler prior to this hospitalization that will significantly affect Transcranial Doppler (TCD) parameters. Patients with abnormalities not likely to affect TCD parameters or known normal TCDs despite abnormal cerebral hemodynamic studies will still be included
- Pre-Existing neurological deficits impairing quality of life
- Absence of temporal windows
- Presence of skull defects that may affect the feasibility of TCD windows
- Co-existing dialysis or other forms of renal replacement therapy
- Pregnant patients
- Patients on palliative care pathway awaiting de-escalation
- Patient on comfort care
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Wake Forest University Health Sciences
Winston-Salem, North Carolina, 27157, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Aarti Sarwal, MD
Wake Forest University Health Sciences
- PRINCIPAL INVESTIGATOR
Connor O'Brien
University of California, San Francisco
- PRINCIPAL INVESTIGATOR
Ashish Khanna, MD
Wake Forest University Health Sciences
- PRINCIPAL INVESTIGATOR
John Gaillard, MD
Wake Forest University Health Sciences
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 13, 2023
First Posted
June 29, 2023
Study Start
May 22, 2024
Primary Completion
December 22, 2025
Study Completion
December 22, 2025
Last Updated
April 2, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ANALYTIC CODE
- Time Frame
- Beginning 3 months and ending 5 years following article publication.
- Access Criteria
- Researchers who provide a methodologically sound proposal.
Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices).